Find Research outputs

Search results

• Review article

  Newer concepts in the medical management of patients with congestive heart failure

  Weintraub, N. L. & Chaitman, B. R., May 1993, In: Clinical Cardiology. 16, 5, p. 380-390 11 p.

  Research output: Contribution to journal › Review article › peer-review

  • Heart Failure 100%
  • Digitalis Glycosides 41%
  • Cardiac Arrhythmias 31%
  • Angiotensin-Converting Enzyme Inhibitors 24%
  • Anterior Wall Myocardial Infarction 18%
  9 Scopus citations

• Newer-generation ventricular assist devices

  Agarwal, S. & High, K. M., Jun 2012, In: Best Practice and Research: Clinical Anaesthesiology. 26, 2, p. 117-130 14 p.

  Research output: Contribution to journal › Review article › peer-review

  • Heart-Assist Devices 100%
  • Equipment and Supplies 50%
  • United States Food and Drug Administration 28%
  • Pressure 18%
  • Transplants 17%
  33 Scopus citations

• Newer hormonal pharmacotherapies for heart failure

  Yandrapalli, S., Jolly, G., Biswas, M., Rochlani, Y., Harikrishnan, P., Aronow, W. S. & Lanier, G. M., Jan 2 2018, In: Expert Review of Endocrinology and Metabolism. 13, 1, p. 35-49 15 p.

  Research output: Contribution to journal › Review article › peer-review

  • Heart Failure 100%
  • Drug Therapy 80%
  • BAY 94-8862 27%
  • macitentan 24%
  • Ularitide 24%
  1 Scopus citations

• New Frontiers and Challenges for Single-Cell Electrochemical Analysis

  Zhang, J., Zhou, J., Pan, R., Jiang, D., Burgess, J. & Chen, H. Y., Feb 23 2018, In: ACS Sensors. 3, 2, p. 242-250 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Electrochemical cells 100%
  • Electrochemistry 99%
  • electrochemical cells 92%
  • Optoelectronic devices 82%
  • Biological systems 82%
  24 Scopus citations

• New frontiers in cochlear implantation: Acoustic plus electric hearing, hearing preservation, and more

  Mowry, S. E., Woodson, E. & Gantz, B. J., Feb 2012, In: Otolaryngologic Clinics of North America. 45, 1, p. 187-203 17 p.

  Research output: Contribution to journal › Review article › peer-review

  • Cochlear Implantation 100%
  • Acoustics 78%
  • Hearing 70%
  • Cochlear Implants 30%
  • Technology 17%
  28 Scopus citations

• New help, new hope

  Hess, D. C., May 1 2000, In: Consultant. 40, 6, p. 1085-1094 10 p.

  Research output: Contribution to journal › Review article › peer-review

  • Multiple Sclerosis 100%
  • Interferon beta-1b 87%
  • Interferon beta-1a 84%
  • Glatiramer Acetate 82%
  • Relapsing-Remitting Multiple Sclerosis 70%

• New Inhaled Antimicrobial Formulations for Use in the Cystic Fibrosis Patient Population

  Campbell, C. T., McCaleb, R. & Manasco, K. B., Feb 1 2016, In: Annals of Pharmacotherapy. 50, 2, p. 133-140 8 p.

  Research output: Contribution to journal › Review article › peer-review

  • Cystic Fibrosis 100%
  • Levofloxacin 99%
  • Amikacin 96%
  • Tobramycin 77%
  • Vancomycin 65%
  10 Scopus citations

• New Insights: MicroRNA Function in CNS Development and Psychiatric Diseases

  Liu, Q., Zhang, L. & Li, H., Apr 1 2018, In: Current Pharmacology Reports. 4, 2, p. 132-144 13 p.

  Research output: Contribution to journal › Review article › peer-review

  • MicroRNA 100%
  • Central Nervous System Diseases 89%
  • MicroRNAs 68%
  • Mental Disorders 66%
  • Developmental 32%
  4 Scopus citations

• New insights into hypertension-associated erectile dysfunction

  Nunes, K. P., Labazi, H. & Webb, R. C., Mar 2012, In: Current opinion in nephrology and hypertension. 21, 2, p. 163-170 8 p.

  Research output: Contribution to journal › Review article › peer-review

  • Erectile Dysfunction 100%
  • Hypertension 60%
  • Antihypertensive Agents 21%
  • Phosphodiesterase 5 Inhibitors 10%
  • Quality of Life 10%
  59 Scopus citations

• New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistance

  Kantarjian, H. M., Talpaz, M., Giles, F., O'Brien, S. & Cortes, J., Dec 19 2006, In: Annals of internal medicine. 145, 12, p. 913-923 11 p.

  Research output: Contribution to journal › Review article › peer-review

  • Imatinib Mesylate 100%
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive 92%
  • 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide 50%
  • Protein-Tyrosine Kinases 32%
  • Disease Progression 28%
  213 Scopus citations

• Newly identified water-borne protein pheromones interact with attractin to stimulate mate attraction in Aplysia

  Cummins, S. F., Nichols, A. E., Schein, C. H. & Nagle, G. T., Mar 2006, In: Peptides. 27, 3, p. 597-606 10 p.

  Research output: Contribution to journal › Review article › peer-review

  • Aplysia 100%
  • Pheromones 98%
  • Pheromone 91%
  • Fertilins 70%
  • Ovum 55%
  33 Scopus citations

• New Metrics in High-Resolution and High-Definition Anorectal Manometry

  Seo, M., Joo, S., Jung, K. W., Song, E. M., Rao, S. S. C. & Myung, S. J., Dec 1 2018, In: Current Gastroenterology Reports. 20, 12, 57.

  Research output: Contribution to journal › Review article › peer-review

  • Manometry 100%
  • Rectal Diseases 53%
  • Fecal Incontinence 22%
  • Constipation 18%
  6 Scopus citations

• New Myc-interacting proteins: A second Myc network emerges

  Sakamuro, D. & Prendergast, G. C., May 13 1999, In: Oncogene. 18, 19, p. 2942-2954 13 p.

  Research output: Contribution to journal › Review article › peer-review

  • Staphylococcal Protein A 100%
  • Apoptosis 52%
  • Cell Cycle 45%
  • Proto-Oncogene Proteins c-myc 41%
  • Retinoblastoma Protein 36%
  149 Scopus citations

• New perspective of CLC-KB/2 CL^- channel physiology in the distal renal tubule

  Zaika, O., Tomilin, V., Mamenko, M., Bhalla, V. & Pochynyuk, O., May 15 2016, In: American Journal of Physiology - Renal Physiology. 310, 10, p. F923-F930

  Research output: Contribution to journal › Review article › peer-review

  • Distal Kidney Tubule 100%
  • Type 3 Bartter syndrome 62%
  • Water-Electrolyte Balance 39%
  • Kidney 34%
  • Insulin-Like Growth Factor I 32%
  19 Scopus citations

• New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy

  Guo, G. & Cui, Y., Mar 24 2015, In: Journal for ImmunoTherapy of Cancer. 3, 1, 9.

  Research output: Contribution to journal › Review article › peer-review

  • Tumor Microenvironment 100%
  • Immunotherapy 84%
  • DNA Damage 31%
  • Neoplasms 31%
  • Genetic Suppression 16%
  23 Scopus citations

• New research on back pain, diet and diabetes, advanced care planning, and other issues frequently seen in family medicine

  Bowman, M. A., Neale, A. V. & Seehusen, D. A., Dec 2019, In: Journal of the American Board of Family Medicine. 32, 6, p. 759-762 4 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Preexisting Condition Coverage 100%
  • Back Pain 85%
  • chronic illness 82%
  • pain 80%
  • Medicine 61%

• New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: Translational and sex-specific effects

  Davel, A. P., Jaffe, I. Z., Tostes, R. C., Jaisser, F. & Belin de Chantemele, E. J., Oct 1 2018, In: American Journal of Physiology - Heart and Circulatory Physiology. 315, 4, p. H989-H999

  Research output: Contribution to journal › Review article › peer-review

  • Mineralocorticoid Receptors 100%
  • Aldosterone 79%
  • Cardiovascular Diseases 55%
  • Obesity 26%
  • Leptin 25%
  13 Scopus citations

• New strategies in chronic myeloid leukemia

  Kantarjian, H. M. & Cortes, J., May 2006, In: International Journal of Hematology. 83, 4, p. 289-293 5 p.

  Research output: Contribution to journal › Review article › peer-review

  • Imatinib Mesylate 100%
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive 92%
  • Homoharringtonine 36%
  • Clinical Trials 28%
  • Decitabine 28%
  22 Scopus citations

• New strategies in peripheral T-cell lymphoma: Understanding tumor biology and developing novel therapies

  Dunleavy, K., Piekarz, R. L., Zain, J., Janik, J. E., Wilson, W. H., O'Connor, O. A. & Bates, S. E., Dec 1 2010, In: Clinical Cancer Research. 16, 23, p. 5608-5617 10 p.

  Research output: Contribution to journal › Review article › peer-review

  • Peripheral T-Cell Lymphoma 100%
  • Anaplastic Large-Cell Lymphoma 98%
  • Anaplastic Lymphoma Kinase 48%
  • Anthracyclines 41%
  • B-Cell Lymphoma 37%
  17 Scopus citations

• New targeted approaches in chronic myeloid leukemia

  Cortes, J. & Kantarjian, H., Dec 1 2005, In: Journal of Clinical Oncology. 23, 26, p. 6316-6324 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Imatinib Mesylate 100%
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive 92%
  • Cytogenetics 34%
  • src-Family Kinases 20%
  • Stem Cell Transplantation 18%
  42 Scopus citations

• New tools and approaches for family physicians

  Seehusen, D. A., Bowman, M. A. & Neale, A. V., Nov 1 2015, In: Journal of the American Board of Family Medicine. 28, 6, p. 689-692 4 p.

  Research output: Contribution to journal › Review article › peer-review

  • family physician 100%
  • Family Physicians 87%
  • Patient Care 40%
  • acupuncture 36%
  • Social Media 32%
  1 Scopus citations

• New treatment alternatives for gallstone disease

  Affronti, J. P. & Putnam, W. S., Jan 1 1991, In: Hospital Formulary. 26, 5, p. 399-414 16 p.

  Research output: Contribution to journal › Review article › peer-review

• New treatment for acute myelogenous leukemia

  DiNardo, C. D. & Cortes, J. E., Jan 1 2015, In: Expert Opinion on Pharmacotherapy. 16, 1, p. 95-106 12 p.

  Research output: Contribution to journal › Review article › peer-review

  • Acute Myeloid Leukemia 100%
  • Epigenomics 22%
  • Therapeutics 17%
  • Cytarabine 14%
  • Anthracyclines 14%
  23 Scopus citations

• Next generation sequencing: Advances in characterizing the Methylome

  Taylor, K. H., Shi, H. & Caldwell, C. W., Sep 2010, In: Genes. 1, 2, p. 143-165 23 p.

  Research output: Contribution to journal › Review article › peer-review

  • Epigenome 100%
  • High-Throughput Nucleotide Sequencing 76%
  • Lymphoma 66%
  • Technology 52%
  • Epigenomics 35%
  3 Scopus citations

• NF-κB-inducing kinase regulates selected gene expression in the Nod2 signaling pathway

  Pan, Q., Kravchenko, V., Katz, A., Huang, S., Ii, M., Mathison, J. C., Kobayashi, K., Flavell, R. A., Schreiber, R. D., Goeddel, D. & Ulevitch, R. J., Apr 2006, In: Infection and Immunity. 74, 4, p. 2121-2127 7 p.

  Research output: Contribution to journal › Review article › peer-review

  • phosphotransferases (kinases) 100%
  • Phosphotransferases 90%
  • gene expression 70%
  • Gene Expression 70%
  • mice 67%
  44 Scopus citations

• Niacin and butyrate: Nutraceuticals targeting dysbiosis and intestinal permeability in parkinson’s disease

  Karunaratne, T. B., Okereke, C., Seamon, M., Purohit, S., Wakade, C. & Sharma, A., Jan 2021, In: Nutrients. 13, 1, p. 1-13 13 p., 28.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • dysbiosis 100%
  • Parkinson disease 88%
  • Butyrates 81%
  • Dysbiosis 81%
  • Niacin 80%
  1 Scopus citations

• Niacin for Parkinson's disease

  Seamon, M., Purohit, S., Giri, B., Baban, B., Morgan, J., Chong, R. & Wakade, C., Feb 1 2020, In: Clinical and Experimental Neuroimmunology. 11, 1, p. 47-56 10 p.

  Research output: Contribution to journal › Review article › peer-review

  • Niacin 100%
  • Parkinson Disease 67%
  • Cognitive Dysfunction 33%
  • coenzyme Q10 26%
  • Clinical Trials 26%
  2 Scopus citations

• Nicotine addiction: Current treatment options

  Andrews, J. & Tingen, M. S., Dec 1 1999, In: Journal of Addictions Nursing. 11, 1, p. 3-12 10 p.

  Research output: Contribution to journal › Review article › peer-review

  • Nicotine 100%
  • Smoking Cessation 33%
  • United States Agency for Healthcare Research and Quality 26%
  • Race Factors 24%
  • Psychology 22%
  3 Scopus citations

• Nicotinic acetylcholine receptor ligands, cognitive function, and preclinical approaches to drug discovery

  Terry, A. V. & Callahan, P. M., Feb 18 2019, In: Nicotine and Tobacco Research. 21, 3, p. 383-394 12 p.

  Research output: Contribution to journal › Review article › peer-review

  • Nicotinic Receptors 100%
  • Drug Discovery 93%
  • nicotine 86%
  • Cognition 71%
  • Ligands 64%
  11 Scopus citations

• Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders

  Terry, A. V., Callahan, P. M. & Hernandez, C. M., Oct 15 2015, In: Biochemical Pharmacology. 97, 4, p. 388-398 11 p.

  Research output: Contribution to journal › Review article › peer-review

  • Disorder 100%
  • Ligands 82%
  • Ligand 51%
  • Antipsychotic 43%
  • Neuroprotective 37%
  29 Scopus citations

• Nilotinib: A phenylamino-pyrimidine derivative with activity against BCR-ABL, KIT and PDGFR kinases

  Quintás-Cardama, A. & Cortes, J., Oct 2008, In: Future Oncology. 4, 5, p. 611-621 11 p.

  Research output: Contribution to journal › Review article › peer-review

  • 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide 100%
  • pyrimidine 84%
  • Imatinib Mesylate 56%
  • Phosphotransferases 53%
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive 41%
  20 Scopus citations

• Nilotinib - A novel Bcr-Abl tyrosine kinase inhibitor for the treatment of chronic myelocytic leukemia and beyond

  Jabbour, E., Cortes, J., Giles, F., O'Brien, S. & Kantarijan, H., Jul 1 2007, In: IDrugs. 10, 7, p. 468-479 12 p.

  Research output: Contribution to journal › Review article › peer-review

  • Nilotinib 100%
  • bcr-abl Fusion Proteins 92%
  • Imatinib 85%
  • 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide 82%
  • Tyrosine Kinase Inhibitor 79%
  11 Scopus citations

• Nilotinib for the treatment of chronic myeloid leukemia: An evidence-based review

  Jabbour, E., Cortes, J. & Kantarjian, H., Dec 1 2009, In: Core Evidence. 4, p. 207-213 7 p.

  Research output: Contribution to journal › Review article › peer-review

  • 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide 100%
  • Imatinib Mesylate 78%
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive 72%
  • bcr-abl Fusion Proteins 37%
  • Leukemia, Myeloid, Chronic Phase 15%
  21 Scopus citations

• Nilotinib for the treatment of Philadelphia-chromosome-positive chronic myeloid leukemia

  Fullmer, A., Kantarjian, H., Cortes, J. & Jabbour, E., Dec 2010, In: Expert Opinion on Pharmacotherapy. 11, 18, p. 3065-3072 8 p.

  Research output: Contribution to journal › Review article › peer-review

  • 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide 100%
  • Philadelphia Chromosome 88%
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive 72%
  • Imatinib Mesylate 67%
  • Leukemia, Myeloid, Chronic Phase 53%
  5 Scopus citations

• Nilotinib therapy in chronic myelogenous leukemia

  Quintás-Cardama, A. & Cortes, J., Oct 1 2007, In: Drugs of Today. 43, 10, p. 691-702 12 p.

  Research output: Contribution to journal › Review article › peer-review

  • 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide 100%
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive 72%
  • Imatinib Mesylate 67%
  • Phosphotransferases 22%
  • Protein-Tyrosine Kinases 17%
  12 Scopus citations

• Ninety-six hours ordeal of priapism induced by paroxetine-A case report and literature review

  Bhat, I. A., Shannon, K. D., Ara, A. & Coe, I., Oct 2015, In: International Journal of Psychiatry in Medicine. 50, 3, p. 326-334 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Priapism 100%
  • Paroxetine 89%
  • Penis 47%
  • Serotonin Uptake Inhibitors 30%
  • Emergencies 21%

• Nitric oxide and homeostatic control: An intercellular signalling molecule contributing to autonomic and neuroendocrine integration?

  Stern, J. E., 2004, In: Progress in Biophysics and Molecular Biology. 84, 2-3, p. 197-215 19 p.

  Research output: Contribution to journal › Review article › peer-review

  • Nitric Oxide 100%
  • Supraoptic Nucleus 71%
  • Paraventricular Hypothalamic Nucleus 64%
  • Homeostasis 20%
  • Neuroanatomy 18%
  83 Scopus citations

• NMDA receptor signaling: Death or survival?

  Luo, T., Wu, W. H. & Chen, B. S., Dec 2011, In: Frontiers in Biology. 6, 6, p. 468-476 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • N-Methyl-D-Aspartate Receptors 100%
  • aspartic acid 94%
  • death 76%
  • receptors 67%
  • brain 45%
  16 Scopus citations

• Nonalcoholic fatty liver disease: Hepatic manifestation of obesity and the metabolic syndrome

  Boppidi, H. & Daram, S. R., Jul 1 2008, In: Postgraduate medicine. 120, 2

  Research output: Contribution to journal › Review article › peer-review

  • Non-alcoholic Fatty Liver Disease 100%
  • Metabolic Syndrome 85%
  • Obesity 64%
  • Liver 47%
  • Epidemics 20%
  57 Scopus citations

• Non-alcoholic steatohepatitis: an overview including treatments with herbals as alternative therapeutics

  Thounaojam, M. C., Navalsinh Jadeja, R., Vijaysinh Devkar, R. & Vadathala Ramachandran, A., 2012, In: Journal of Applied Biomedicine. 10, 3, p. 119-136 18 p.

  Research output: Contribution to journal › Review article › peer-review

  • Antiobesity 100%
  • Fatty Liver 70%
  • Remediation 67%
  • therapeutics 51%
  • Antioxidant Agent 50%
  9 Scopus citations

• Nonarteritic anterior ischemic optic neuropathy.

  Desai, N., Patel, M. R., Prisant, L. M. & Thomas, D. A., Feb 2005, In: Journal of clinical hypertension (Greenwich, Conn.). 7, 2, p. 130-133 4 p.

  Research output: Contribution to journal › Review article › peer-review

  • Ischemic Optic Neuropathy 100%
  • Ocular Vision 40%
  • Eye 29%
  • Hypotension 22%
  • Sleep 18%
  5 Scopus citations

• Noncirrhotic portal hypertension in the adult: case report and review of the literature.

  Almoudarres, M., Vega, K. J. & Trotman, B. W., 1998, In: Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians. 9, 3, p. 53-55 3 p.

  Research output: Contribution to journal › Review article › peer-review

  • Portal Hypertension 100%
  • Hemorrhage 58%
  • Portal Vein 30%
  • Banti's syndrome 24%
  • Surgical Splenorenal Shunt 23%
  5 Scopus citations

• Nonclassic adrenal hyperplasia.

  Azziz, R., 1997, In: Current therapy in endocrinology and metabolism. 6, p. 175-178 4 p.

  Research output: Contribution to journal › Review article › peer-review
  2 Scopus citations

• Non-classic adrenal hyperplasia in hyperandrogenism: A reappraisal

  Morán, C., Knochenhauer, E. S. & Azziz, R., Jan 1 1998, In: Journal of Endocrinological Investigation. 21, 10, p. 707-720 14 p.

  Research output: Contribution to journal › Review article › peer-review
  17 Scopus citations

• Nondosimetric Risk Factors for Radiation-Induced Lung Toxicity

  Kong, F. M. S. & Wang, S., Apr 1 2015, In: Seminars in Radiation Oncology. 25, 2, p. 100-109 10 p.

  Research output: Contribution to journal › Review article › peer-review

  • Radiation 100%
  • Lung 71%
  • Radiotherapy 46%
  • Radiometry 32%
  • Pulmonary Fibrosis 25%
  72 Scopus citations

• Nonfetal Imaging During Pregnancy: Acute Abdomen/Pelvis

  Moreno, C. C., Mittal, P. K. & Miller, F. H., Mar 2020, In: Radiologic Clinics of North America. 58, 2, p. 363-380 18 p.

  Research output: Contribution to journal › Review article › peer-review

  • Acute Abdomen 100%
  • Pelvis 78%
  • Abdominal Pain 70%
  • Pregnant Women 48%
  • Pregnancy 48%

• Noninvasive diagnosis of CAD in women

  Miller, D. D., Dec 1 1995, In: Journal of Myocardial Ischemia. 7, 6, p. 263-268 6 p.

  Research output: Contribution to journal › Review article › peer-review

  • Coronary Artery Disease 100%
  • Myocardial Perfusion Imaging 24%
  • Morbidity 23%
  • Mortality 20%
  • Coronary Artery Bypass 19%
  4 Scopus citations

• Noninvasive diagnosis of myocardial viability

  Miller, D. D., Jan 1 1994, In: Journal of Myocardial Ischemia. 6, 7, p. 22-30 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Myocardial Stunning 100%
  • Myocardium 39%
  • Thallium-201 30%
  • Perfusion Imaging 28%
  • Technetium 27%

• Nonmotor manifestations of Parkinson's disease

  Simuni, T. & Sethi, K. D., Dec 1 2008, In: Annals of Neurology. 64, SUPPL. 2

  Research output: Contribution to journal › Review article › peer-review

  • Parkinson Disease 100%
  • Sleep 23%
  • Neurodegenerative Diseases 12%
  • Alzheimer Disease 11%
  • Depression 9%
  172 Scopus citations

• Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era.

  Champlin, R., de Lima, M., Kebriaei, P., Rondon, G., Fisher, T., Jabbour, E., Cortés, J. E., Kantarjian, H., Anderlini, P., Alousi, A., Hosing, C., Shpall, E., Popat, U., Qazilbash, M., Andersson, B. & Giralt, S., 2009, In: Clinical lymphoma & myeloma. 9 Suppl 3, p. S261-265

  Research output: Contribution to journal › Review article › peer-review

  • Imatinib Mesylate 100%
  • Allogeneic Cells 94%
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive 92%
  • Stem Cell Transplantation 92%
  • Transplantation 19%
  13 Scopus citations